Multiple Sclerosis Clinical Trials in Philadelphia

Showing 181-200 of 634 trials

Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis

NCT04602390

A safety study of ANK-700 in patients with relapsing remitting multiple sclerosis. The study has two parts: Part A - first in human study in which patients receive a single dose of ANK-700 Part B - patients will receive three doses of either ANK-700 or placebo

Multiple Sclerosis (MS)Relapsing Remitting Multiple Sclerosis

Anokion SA34 participantsStarted Nov 2020

Cullman, Alabama, United States • Phoenix, Arizona, United States • Aurora, Colorado, United States +12 more locations

RECRUITINGPhase 1/2< 1 mile

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

NCT04104776

The purpose of this open-label, first-in-human (FIH) trial is to evaluate the safety, tolerability, and preliminary clinical activity of Tulmimetostat as a monotherapy in patients with advanced solid tumors and lymphomas.

Advanced Solid TumorDiffuse Large B Cell LymphomaLymphoma, T-Cell+5 more

Novartis Pharmaceuticals275 participantsStarted Sep 2019

Atlanta, Georgia, United States • Chicago, Illinois, United States • Baltimore, Maryland, United States +57 more locations

Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Multiple Sclerosis Trials in Other Cities

Characterization and Natural History of Williams Syndrome and Other Chromosome 7q11.23 Variants

ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D

A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer

Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of Schizophrenia

Portable Neuromodulation Stimulator Registry for People With Multiple Sclerosis

A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)

Genes and Environment in Multiple Sclerosis

Study of MK-3475 (Pembrolizumab) in Patients With Microsatellite Unstable (MSI) Tumors (Cohort D)

Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice

Trial of H3B-6545, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer

A Study of PF-07260437 in Advanced or Metastatic Solid Tumors

Lipoic Acid for Progressive Multiple Sclerosis (MS)

A Study of Suboptimally Controlled Participants Previously Taking Injectable DMDs for RMS (CLICK-MS)

Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors

Efficacy of Emotionally Focused Therapy Among Spanish Speaking Couples

Other Conditions in Philadelphia